Let’s look at the key reasons that are pushing Macrogenics Inc (MGNX) to new highs

On Friday, Macrogenics Inc (NASDAQ: MGNX) opened lower -4.17% from the last session, before settling in for the closing price of $2.88. Price fluctuations for MGNX have ranged from $2.34 to $21.88 over the past 52 weeks.

Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 18.02%. Company’s average yearly earnings per share was noted -697.81% at the time writing. With a float of $57.80 million, this company’s outstanding shares have now reached $62.76 million.

Considering the fact that the conglomerate employs 339 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 91.14%, operating margin of -75.78%, and the pretax margin is -69.07%.

Macrogenics Inc (MGNX) Breakdown of a Key Holders of the stock

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Macrogenics Inc is 7.92%, while institutional ownership is 84.47%. The most recent insider transaction that took place on Feb 15 ’25, was worth 1,083. In this transaction VP, Controller & Treasurer of this company sold 423 shares at a rate of $2.56, taking the stock ownership to the 9,532 shares. Before that another transaction happened on Apr 04 ’24, when Company’s Senior VP and General Counsel sold 51,395 for $15.55, making the entire transaction worth $799,148. This insider now owns 0 shares in total.

Macrogenics Inc (MGNX) Recent Fiscal highlights

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.79 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -697.81% per share during the next fiscal year.

Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators

Check out the current performance indicators for Macrogenics Inc (MGNX). In the past quarter, the stock posted a quick ratio of 3.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.23.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.57, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -2.20 in one year’s time.

Technical Analysis of Macrogenics Inc (MGNX)

Compared to the last year’s volume of 0.68 million, its volume of 0.71 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 81.25%. Additionally, its Average True Range was 0.18.

During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 15.22%, which indicates a significant decrease from 61.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 78.06% in the past 14 days, which was higher than the 64.08% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.08, while its 200-day Moving Average is $3.97. Nevertheless, the first resistance level for the watch stands at $2.87 in the near term. At $2.99, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.04. If the price goes on to break the first support level at $2.70, it is likely to go to the next support level at $2.65. Now, if the price goes above the second support level, the third support stands at $2.53.

Macrogenics Inc (NASDAQ: MGNX) Key Stats

There are currently 62,763K shares outstanding in the company with a market cap of 173.23 million. Presently, the company’s annual sales total 58,750 K according to its annual income of -9,060 K. Last quarter, the company’s sales amounted to 110,710 K and its income totaled 56,310 K.